Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patientsInt. J. Clin. Oncol. 2021 Dec 01;26(12)2338-2346, D Ogata, K Tanese, Y Nakamura, M Otsuka, K Namikawa, T Funakoshi, S Yoshikawa, K Tsutsui, K Nakama, S Jinnai, Y Kiyohara, A Takahashi, N Yamazaki
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.